Dr Grace Lidgerwood is a Research Fellow in CERA’s Clinical Genetics team. She has strong experience in human pluripotent stem cell (hPSC) research and tissue engineering, molecular and cellular biology, immunofluorescence, flow cytometry, ELISA and a range of metabolic assays.

Dr Lidgerwood received her PhD from the University of Melbourne in 2018. During her PhD, she developed methods for differentiating iPSCs to retinal cell types for disease modelling and explored the role of endogenous signalling lipids and inflammation in retinal homeostasis.

Her current research is focused on creating more complex hPSC-derived models of neurodegeneration, including organoid and co-culturing methods, bioengineered matrices and 3D printing.

Dr Lidgerwood is an affiliate Postdoctoral Fellow for the ARC Centre for Personalised Therapeutic Technologies (ARC CPTT), an Honorary Fellow of the Department of Surgery, and the Chair of the Early Career Researcher Committee, Australian Society for Stem Cell Research (ASSCR).